文献检索/Therapeutics and Clinical Risk ManagementEM-T3Therapeutics and Clinical Risk Management2025-05-01第 Volume 21 卷，727-736开放获取Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular EventsEduard SidelnikovAmgen (Switzerland)Bethany A. KalichAmgen (United States)Margot Lisa MiglinsAmgen (United States)Jasjit K. MultaniIQVIA (United States)Rifat TulyIQVIA (United States)Kevin HawkinsIQVIA (United States)Usman BaberMount Sinai Hospital开放获取全文去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词PCSK9 inhibitorsPCSK9 monoclonal antibodiestime to treatmentmajor adverse cardiovascular eventscardiovascular outcomessecondary preventionmyocardial infarctionstrokecoronary revascularizationtime to eventstatin therapyLDL cholesterol loweringhypercholesterolemialipid-lowering therapydelayed treatment initiationtime-dependent effectscardiovascular risk stratification参考文献16引证文献0相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
